Peter Lau
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 02, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanoma.Lorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt
|Oct 09, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).Peter Kar Han Lau, Breon Feran, Lorey Smith
|Dec 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.Emily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom
|Jan 17, 2020
Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis.Bedrich L Eckhardt, Yuan Cao, Andrew D Redfern
|Apr 03, 2019
Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case series.Patricia D Banks, Arian Lasocki, Peter K H Lau
|Feb 06, 2019
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy.Emily J Lelliott, Carleen Cullinane, Claire A Martin
Pageof 1
Frequent Collaborators
3 joint publications
Karen E Sheppard
2 joint publications
Arian Lasocki
2 joint publications
Bruce Latham
1 joint publications
Mark Shackleton
1 joint publications
Yuan Cao
1 joint publications
Lap Hing Chi
1 joint publications
Belinda S Parker
1 joint publications
Sherene Loi
1 joint publications
Naoto T Ueno
1 joint publications
Emily J Lelliott
